The present invention relates to compounds that are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme, The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and other diseases and conditions that are mediated by excessive glucocorticoid action.
本发明涉及抑制11-β-羟基类
固醇脱氢酶1型酶的化合物。本发明还涉及使用11-β-羟基类
固醇脱氢酶1型酶
抑制剂治疗非
胰岛素依赖性2型糖尿病、
胰岛素抵抗、肥胖症、脂质代谢紊乱、代谢综合症和其他由过度糖皮质激素作用介导的疾病和病症。